Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

How should we listen to ECHO?

Noguchi LM, Simelela PN.

Lancet. 2019 Jul 27;394(10195):275-276. doi: 10.1016/S0140-6736(19)31387-X. Epub 2019 Jun 13. No abstract available.

2.

Pharmacokinetics of Dapivirine Transfer into Blood Plasma, Breast Milk, and Cervicovaginal Fluid of Lactating Women Using the Dapivirine Vaginal Ring.

Noguchi LM, Hoesley C, Kelly C, Scheckter R, Bunge K, Nel A, Marzinke MA, Hendrix CW, Dezzutti CS, Hillier SL, Bogen DL, Piper JM, Beigi RH.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e01930-18. doi: 10.1128/AAC.01930-18. Print 2019 Mar.

3.

Pregnancy and Infant Outcomes Among Women Using the Dapivirine Vaginal Ring in Early Pregnancy.

Makanani B, Balkus JE, Jiao Y, Noguchi LM, Palanee-Phillips T, Mbilizi Y, Moodley J, Kintu K, Reddy K, Kabwigu S, Jeenariain N, Harkoo I, Mgodi N, Piper J, Rees H, Scheckter R, Beigi R, Baeten JM.

J Acquir Immune Defic Syndr. 2018 Dec 15;79(5):566-572. doi: 10.1097/QAI.0000000000001861.

PMID:
30383589
4.

Acceptability of and Adherence to an Antiretroviral-Based Vaginal Microbicide among Pregnant Women in the United States.

Montgomery ET, Noguchi LM, Dai JY, Pan J, Biggio J, Hendrix C, Isaacs K, Watts DH, Schwartz JL, Piper J, Beigi R.

AIDS Behav. 2018 Feb;22(2):402-411. doi: 10.1007/s10461-017-1811-9.

5.

Treatment of infections during pregnancy: Progress and challenges.

Noguchi LM, Beigi RH.

Birth Defects Res. 2017 Mar 15;109(5):387-390. doi: 10.1002/bdr2.1005. Review.

PMID:
28398676
6.

A randomized safety and pharmacokinetic trial of daily tenofovir 1% gel in term and near-term pregnancy.

Beigi RH, Noguchi LM, Montgomery E, Biggio J, Hendrix CW, Marzinke MA, Dai JY, Pan J, Kunjara Na Ayudhya R, Schwartz JL, Isaacs K, Piper JM, Watts DH.

J Int AIDS Soc. 2016 Sep 21;19(1):20990. doi: 10.7448/IAS.19.1.20990. eCollection 2016.

7.

Detectable Tenofovir Levels in Breast-Feeding Infants of Mothers Exposed to Topical Tenofovir.

Noguchi LM, Montgomery ET, Biggio JR, Hendrix CW, Bogen DL, Hillier SL, Dai JY, Piper JM, Marzinke MA, Dezzutti CS, Isaacs SK, Schwartz JL, Watts DH, Beigi RH.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5616-9. doi: 10.1128/AAC.00645-16. Print 2016 Sep.

8.

Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk - Authors' reply.

Noguchi LM, Richardson BA, Balkus JE, Marrazzo JM.

Lancet HIV. 2015 Sep;2(9):e366-7. doi: 10.1016/S2352-3018(15)00155-1. Epub 2015 Aug 26. No abstract available.

PMID:
26423547
9.

Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.

Noguchi LM, Richardson BA, Baeten JM, Hillier SL, Balkus JE, Chirenje ZM, Bunge K, Ramjee G, Nair G, Palanee-Phillips T, Selepe P, van der Straten A, Parikh UM, Gomez K, Piper JM, Watts DH, Marrazzo JM; VOICE Study Team.

Lancet HIV. 2015 Jul;2(7):e279-87.

Supplemental Content

Loading ...
Support Center